Last reviewed · How we verify

NCT05603507: chestburn

Inspiratory Muscle Training in Children With Chest Burn

Completed NA Last updated 2 November 2022
What this trial tests

NA trial testing inspiratory muscle training in Burns in 40 participants. Completed in 15 May 2022.

Timeline
10 September 2021
Primary endpoint
9 April 2022
15 May 2022

Quick facts

Lead sponsorQassim University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date10 September 2021
Primary completion9 April 2022
Estimated completion15 May 2022
Sites1 location across Saudi Arabia

Drugs / interventions tested

Conditions studied

Sponsor

Qassim University

Who can join

Adults 10 to 18, any sex, with Burns or Respiratory Function Impaired. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

8 weeks of inspiratory muscle training combined with a pulmonary rehabilitation program increases respiratory muscle strength, pulmonary function, functional capacity, and quality of life in chest burned children.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of inspiratory muscle training

Trials testing the same drug.

Other recruiting trials for Burns

Currently open trials in the same condition.

Other Qassim University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05603507.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing